Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo

Congdon, Erin E., Wu, Jessica W., Myeku, Natura, Figueroa, Yvette H., Herman, Mathieu, Marinec, Paul S., Gestwicki, Jason E., Dickey, Chad A. +2 more·2012·Autophagy

Cited by (300)

Items 101–200 of 300

  1. Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles
    Deng, Zhiqiang, Dong, Yu, Zhou, Xiaoting, Lu, Jia-Hong, Yue, Zhenyu · 2022 · Acta Pharmaceutica Sinica B
  2. Mechanistic Studies Unravel the Complexity Inherent in Tau Aggregation Leading to Alzheimer’s Disease and the Tauopathies
    Gayathri Ramachandran, Jayant B. Udgaonkar · 2013 · Biochemistry
  3. Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation
    Todd J. Cohen, Brian H. Constance, Andrew W. Hwang, Michael James, Chao‐Xing Yuan · 2016 · PLoS ONE
  4. Attenuation of synaptic toxicity and MARK4/PAR1-mediated Tau phosphorylation by methylene blue for Alzheimer’s disease treatment
    Wenchao Sun, Seongsoo Lee, Xiaoran Huang, Song Liu, Mohammed Inayathullah, Kwang-Min Kim, Hongxiang Tang, John Wesson Ashford, Jayakumar Rajadas · 2016 · Scientific Reports
  5. Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation
    Mingfei Zhao, FENG LIANG, Hangdi Xu, Wei Xing Yan, Jianmin Zhang · 2015 · Molecular Medicine Reports
  6. Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
    Hui-Yun Chang, Tzu‐Kang Sang, Ann‐Shyn Chiang · 2018 · Journal of Biomedical Science
  7. Chemical Chaperones as Novel Drugs for Parkinson’s Disease
    Jordi Pujols, Samuel Peña‐Díaz, Irantzu Pallarès, Salvador Ventura · 2020 · Trends in Molecular Medicine
  8. Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer’s disease
    Narendran Annadurai, Khushboo Agrawal, Petr Džubák, Marián Hajdúch, Viswanath Das · 2017 · Cellular and Molecular Life Sciences
  9. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
    Seripa, Davide, Solfrizzi, Vincenzo, Imbimbo, Bruno P., Daniele, Antonio, Santamato, Andrea, Lozupone, Madia, Zuliani, Giovanni, Greco, Antonio, Logroscino, Giancarlo, Panza, Francesco · 2016 · Expert Review of Neurotherapeutics
  10. Diagnosis and Treatment of Alzheimer’s Disease:
    Emily Bomasang-Layno, Rachel Bronsther · 2021 · Delaware Journal of Public Health
  11. Methylene Blue Modulates β-Secretase, Reverses Cerebral Amyloidosis, and Improves Cognition in Transgenic Mice
    Takashi Mori, Naoki Koyama, Tatsuya Segawa, Masahiro Maeda, Nobuhiro Maruyama, Noriaki Kinoshita, Huayan Hou, Jun Tan, Terrence Town · 2014 · Journal of Biological Chemistry
  12. Tau clearance improves astrocytic function and brain glutamate-glutamine cycle
    Michaeline L. Hebron, Monica Javidnia, Charbel Moussa · 2018 · Journal of the Neurological Sciences
  13. Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy
    Zagórska, Agnieszka, Jaromin, Anna · 2020 · Molecules
  14. Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
    Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta · 2024 · Neurochemistry International
  15. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer’s Disease Mouse Model
    Zakaria, Aya, Hamdi, Nabila, Abdel-Kader, Reham Mahmoud · 2016 · Molecular Neurobiology
  16. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease
    Jaspreet Kalra, Aamir Ghafoor Khan · 2015 · European Journal of Pharmacology
  17. Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models
    I. Lonskaya, M. Hebron, Wenqiang Chen, J. Schachter, C. Moussa · 2014 · Molecular Neurodegeneration
  18. Modeling Prion-Like Processing of Tau Protein in Alzheimer’s Disease for Pharmaceutical Development
    Claude M. Wischik, Björn O. Schelter, Damon Wischik, John M. D. Storey, Charles R. Harrington · 2017 · Journal of Alzheimer s Disease
  19. Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers
    Ryan P. Kreiser, Aidan K. Wright, Natalie R. Block, Jared E. Hollows, Lam Tung Nguyen, Kathleen LeForte, Benedetta Mannini, Michele Vendruscolo, Ryan Limbocker · 2020 · International Journal of Molecular Sciences
  20. Methylene blue and its analogues as antidepressant compounds
    Anzelle Delport, Brian Herbert Harvey, Anél Petzer, Jacobus Petrus Petzer · 2017 · Metabolic Brain Disease
  21. Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease
    Bjoern O. Schelter, Helen Shiells, Thomas C. Baddeley, Christopher M. Rubino, Harish Ganesan, Jeffrey Hammel, Vesna Vuksanović, Roger T. Staff, Alison D. Murray, Luc Bracoud et al. · 2019 · Journal of Alzheimer s Disease
  22. Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy
    Ono, Maiko, Komatsu, Masaaki, Ji, Bin, Takado, Yuhei, Shimojo, Masafumi, Minamihisamatsu, Takeharu, Warabi, Eiji, Yanagawa, Toru, Matsumoto, Gen, Aoki, Ichio et al. · 2022 · Aging Cell
  23. Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer’s Disease: A Systematic Review
    Reinhard Gruendler, Berit Hippe, Vesna Šendula Jengić, Borut Peterlin, Alexander G. Haslberger · 2020 · Molecules
  24. Inhibition of amyloid-beta peptide aggregation rescues the autophagic deficits in the TgCRND8 mouse model of Alzheimer disease
    Aaron Y. Lai, JoAnne McLaurin · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  25. The Effects of Methylene Blue on Autophagy and Apoptosis in MRI-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core
    Jiang Zhao, Lora Talley Watts, Shi‐Liang Huang, Qiang Shen, Pavel Rodriguez, Chunhua Chen, Changman Zhou, Timothy Q. Duong · 2015 · PLoS ONE
  26. Tau as a potential therapeutic target for ischemic stroke
    Xin Chen, Hua Jiang · 2019 · Aging
  27. Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy
    Tara L. Spires‐Jones, Taylor Friedman, Rose Pitstick, Manuela Polydoro, Allyson D. Roe, George A. Carlson, Bradley T. Hyman · 2014 · Neuroscience Letters
  28. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
    Yuan Zhao, Yidan Zhang, Jian Zhang, Xiangjian Zhang, Guofeng Yang · 2020 · Current Neuropharmacology
  29. Activation of a7 Nicotinic Acetylcholine Receptor Protects Against Oxidant Stress Damage Through Reducing Vascular Peroxidase-1 in a JNK Signaling-Dependent Manner in Endothelial Cells
    Dongjie Li, Ting Zhao, Rujuan Xin, Yuan‐Yuan Wang, Yi-Bo Fei, Fu‐Ming Shen · 2014 · Cellular Physiology and Biochemistry
  30. Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases
    Amanda K. Davis, William B. Pratt, Andrew P. Lieberman, Yoichi Osawa · 2019 · Cellular and Molecular Life Sciences
  31. PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo
    Michiaki Okuda, Ichiro Hijikuro, Yuki Fujita, Xiaofeng Wu, Shinichi Nakayama, Yoko Sakata, Yuji Noguchi, Makoto Ogo, Shigeru Akasofu, Yoshimasa Ito et al. · 2015 · PLoS ONE
  32. cdc-Like/Dual-Specificity Tyrosine Phosphorylation–Regulated Kinases Inhibitor Leucettine L41 Induces mTOR-Dependent Autophagy: Implication for Alzheimer’s Disease
    Xavier Fant, Émilie Durieu, Gaëtan Chicanne, Bernard Payrastre, Diego Sbrissa, Assia Shisheva, Emmanuelle Limanton, François Carreaux, Jean Pierre Bazureau, Laurent Meijer · 2013 · Molecular Pharmacology
  33. Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine
    Prateep Pakavathkumar, Gyanesh Sharma, Vikas Kaushal, Bénédicte Foveau, Andrea Claire LeBlanc · 2015 · Scientific Reports
  34. Vitis amurensis Rupr: A review of chemistry and pharmacology
    Qing Chen, Lichao Diao, Hua Song, Xuan Zhu · 2017 · Phytomedicine
  35. New Insights Into Autophagy Dysfunction Related to Amyloid Beta Toxicity and Neuropathology in Alzheimer's Disease
    Claudia Ntsapi, Dumisile Lumkwana, Chrisna Swart, André du Toit, Ben Loos · 2017 · International review of cytology
  36. The emerging role of the sigma-1 receptor in autophagy: hand-in-hand targets for the treatment of Alzheimer’s
    Mani Iyer Prasanth, Dicson Sheeja Malar, Tewin Tencomnao, James Michael Brimson · 2021 · Expert Opinion on Therapeutic Targets
  37. mTOR-dependent TFEB activation and TFEB overexpression enhance autophagy-lysosome pathway and ameliorate Alzheimer's disease-like pathology in diabetic encephalopathy
    Lizhen Cheng, Yixin Chen, Donghao Guo, Yuan Zhong, Wei Li, Yijia Lin, Ya Miao · 2023 · Cell Communication and Signaling
  38. Methylene blue induces macroautophagy through 5′ adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation
    Luokun Xie, Wenjun Li, Ali Winters, Fang Yuan, Kunlin Jin, Shao‐Hua Yang · 2013 · Frontiers in Cellular Neuroscience
  39. Methylene blue rescues heart defects in a Drosophila model of Friedreich's ataxia
    Hervé Tricoire, Amandine Palandri, Arthur Bourdais, Jean‐Michel Camadro, Véronique Monnier · 2013 · Human Molecular Genetics
  40. Association Between Atg5-independent Alternative Autophagy and Neurodegenerative Diseases
    Shinya Honda, Satoko Arakawa, Hirofumi Yamaguchi, Satoru Torii, Hajime Tajima Sakurai, Masatsune Tsujioka, Michiko Murohashi, Shigeomi Shimizu · 2020 · Journal of Molecular Biology
  41. Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia
    Helen Shiells, Bjoern O. Schelter, Peter Bentham, Thomas C. Baddeley, Christopher M. Rubino, Harish Ganesan, Jeffrey Hammel, Vesna Vuksanović, Roger T. Staff, Alison D. Murray et al. · 2020 · Journal of Alzheimer s Disease
  42. Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle
    Mark P. Mattson · 2015 · npj Aging and Mechanisms of Disease
  43. Amurensin G induces autophagy and attenuates cellular toxicities in a rotenone model of Parkinson’s disease
    Hyun-Wook Ryu, Won Keun Oh, Ik‐Soon Jang, Junsoo Park · 2013 · Biochemical and Biophysical Research Communications
  44. Tau Clearance Mechanisms
    Maoping Tang, Jarreau Harrison, Carol A. Deaton, Gail V.W. Johnson · 2019 · Advances in experimental medicine and biology
  45. Pharmacological Modulators of Tau Aggregation and Spreading
    Antonio Dominguez‐Meijide, Eftychia Vasili, Tiago F. Outeiro · 2020 · Brain Sciences
  46. Genipin Attenuates Tau Phosphorylation and Aβ Levels in Cellular Models of Alzheimer’s Disease
    Meiting Li, Nan Cai, Liang Gu, Lijun Yao, Decheng Bi, Weishan Fang, Zhijian Lin, Yan Ling Wu, Hong Yuan Xu, Hui Li et al. · 2021 · Molecular Neurobiology
  47. Molecular Mechanisms of the Neuroprotective Effect of Methylene Blue
    Artem P. Gureev, Irina S. Sadovnikova, Vasily N. Popov · 2022 · Biochemistry (Moscow)
  48. Preserved autophagy in cognitively intact non‐demented individuals with Alzheimer's neuropathology
    Tumurbaatar, Batbayar, Fracassi, Anna, Scaduto, Pietro, Guptarak, Jutatip, Woltjer, Randall, Jupiter, Daniel, Taglialatela, Giulio · 2023 · Alzheimer's & Dementia
  49. Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone
    Jay K. Singh, Darren M. Hutt, Bradley D. Tait, Naihsuan C. Guy, Jeffrey C. Sivils, Nina R. Ortiz, Ashley N. Payan, Shravan Kumar Komaragiri, Jazzmin Jovonna Owens, David S. Culbertson et al. · 2020 · Cell chemical biology
  50. Alzheimer’s disease: phenotypic approaches using disease models and the targeting of tau protein
    Elisabetta Lauretti, Domenico Praticò · 2020 · Expert Opinion on Therapeutic Targets
  51. Impact of Heat Shock Proteins in Neurodegeneration: Possible Therapeutical Targets
    Beretta, Giangiacomo, Shala, Aida Loshaj · 2022 · Annals of Neurosciences
  52. Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy
    Seulgi Shin, Do‐Hee Kim, Ji Yeon Song, Hyeanjeong Jeong, Seung Jae Hyeon, Neil W. Kowall, Hoon Ryu, Ae Nim Pae, Sungsu Lim, Yun Kyung Kim · 2020 · Progress in Neurobiology
  53. A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
    Karima Schwab, Silke Frahm, David Horsley, Janet E. Rickard, Valeria Melis, Elizabeth A. Goatman, Mandy Magbagbeolu, Morag Douglas, Michael Leith, Thomas C. Baddeley et al. · 2018 · Frontiers in Molecular Neuroscience
  54. Aberrant Autophagy and Parkinsonism: Does Correction Rescue from Disease Progression?
    Abhishek Kumar Mishra, Mohd Sami Ur Rasheed, Saurabh Shukla, Manish Kumar Tripathi, Anubhuti Dixit, Mahendra Pratap Singh · 2014 · Molecular Neurobiology
  55. Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model
    Gernot Riedel, Jochen Klein, Grażyna Niewiadomska, Constantin Kondak, Karima Schwab, Dilyara Lauer, Mandy Magbagbeolu, Marta Steczkowska, Maciej Zadrożny, Małgorzata Wydrych et al. · 2020 · Current Alzheimer Research
  56. Specific Degradation of Endogenous Tau Protein and Inhibition of Tau Fibrillation by Tanshinone IIA through the Ubiquitin–Proteasome Pathway
    Nan Cai, Jiajie Chen, Decheng Bi, Liang Gu, Lijun Yao, Xiuting Li, Hui Li, Hong Yuan Xu, Zhangli Hu, Qiong Liu et al. · 2020 · Journal of Agricultural and Food Chemistry
  57. Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer’s Disease
    Md. Ataur Rahman, MD. Hasanur Rahman, A. N. M. Mamun-Or-Rashid, Hongik Hwang, Sooyoung Chung, Bonglee Kim, Hyewhon Rhim · 2022 · Biomedicines
  58. Potential synergy between tau aggregation inhibitors and tau chaperone modulators
    Laura J. Blair, Bo Zhang, Chad A. Dickey · 2013 · Alzheimer s Research & Therapy
  59. Multifunctional nano-enabled delivery systems in Alzheimer's disease management
    Chengyuan Qian, Chengyi Yuan, Changhong Li, Hao Liu, Xiaohui Wang · 2020 · Biomaterials Science
  60. Alginate-Derived Mannuronate Oligosaccharide Attenuates Tauopathy through Enhancing Autophagy
    Decheng Bi, Shifeng Xiao, Zhijian Lin, Lijun Yao, Weishan Fang, Yan Ling Wu, Hong Yuan Xu, Jun Lu, Xu Xu · 2021 · Journal of Agricultural and Food Chemistry
  61. Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease
    Susana Cardoso, Raquel Maria Fino Seiça, Paula Isabel Moreira · 2016 · Expert Review of Neurotherapeutics
  62. Therapeutic modulation of neurogenesis to improve hippocampal plasticity and cognition in aging and Alzheimer's disease
    Mostafa Mostafa, Ahmed Disouky, Orly Lazarov · 2025 · Neurotherapeutics
  63. Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
    Luke McAlary, Steven Samuel Plotkin, Neil R. Cashman · 2019 · CNS Drugs
  64. Molecular interaction of stress granules with Tau and autophagy in Alzheimer's disease
    Qin-Yuan Yu, Lingqi Ye, Honglei Li · 2022 · Neurochemistry International
  65. Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies
    Sahabudeen Sheik Mohideen, Yasutoyo Yamasaki, Yasuhiro Omata, Leo Tsuda, Yuji Yoshiike · 2015 · Scientific Reports
  66. Iron-impregnated spent coffee ground biochar for enhanced degradation of methylene blue during cold plasma application
    Jae-Cheol Lee, Hee‐Jun Kim, Hyun‐Woo Kim, Hankwon Lim · 2021 · Journal of Industrial and Engineering Chemistry
  67. Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis
    Yixian Li, Peng Yang, Ran Meng, Shuting Xu, Lingling Zhou, Kang Qian, Pengzhen Wang, Yunlong Cheng, Dongyu Sheng, Minjun Xu et al. · 2023 · Acta Pharmaceutica Sinica B
  68. Synthesis, Stereochemical Analysis, and Derivatization of Myricanol Provide New Probes That Promote Autophagic Tau Clearance
    Mackenzie D. Martin, Laurent Calcul, Courtney Smith, Umesh K. Jinwal, Sarah N. Fontaine, April L. Darling, Kent W. Seeley, Łukasz Wojtas, Malathi Narayan, Jason E. Gestwicki et al. · 2015 · ACS Chemical Biology
  69. Methylene blue alleviates experimental autoimmune encephalomyelitis by modulating AMPK/SIRT1 signaling pathway and Th17/Treg immune response
    Jueqiong Wang, Congying Zhao, Peng Kong, Guanyun Bian, Zhe Sun, Yafei Sun, Li Guo, Bin Li · 2016 · Journal of Neuroimmunology
  70. Methylene blue protects dopaminergic neurons against MPTP‐induced neurotoxicity by upregulating brain‐derived neurotrophic factor
    Sunil Bhurtel, Nikita Katila, Sabita Neupane, Sunil Srivastav, Pil‐Hoon Park, Dong‐Young Choi · 2018 · Annals of the New York Academy of Sciences
  71. Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree
    Jie Wen, Fang Fang, Shuhan Guo, Ying Zhang, Xiang-Lei Peng, Weimin Sun, Xiaoran Wei, Jinsheng He, Tao Hung · 2017 · Journal of Molecular Neuroscience
  72. Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules
    Jennifer N. Rauch, Steven H. Olson, Jason E. Gestwicki · 2016 · Cold Spring Harbor Perspectives in Medicine
  73. Paired Helical Filament-Forming Region of Tau (297–391) Influences Endogenous Tau Protein and Accumulates in Acidic Compartments in Human Neuronal Cells
    Saskia J. Pollack, Jasmine E Trigg, Tahmida Khanom, Luca Biasetti, Karen E. Marshall, Youssra K. Al‐Hilaly, Janet E. Rickard, Charles R. Harrington, Claude M. Wischik, Louise C. Serpell · 2020 · Journal of Molecular Biology
  74. 1,3,5-Triazine Nitrogen Mustards with Different Peptide Group as Innovative Candidates for AChE and BACE1 Inhibitors
    Dawid Maliszewski, Agnieszka Wróbel, Beata Kolesińska, Justyna Frączyk, Danuta Drozdowska · 2021 · Molecules
  75. Tau aggregation inhibitors: the future of Alzheimer’s pharmacotherapy?
    Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno Pietro Imbimbo, Andrea Santamato, Madia Lozupone, Rosa Capozzo, Camilla Prete, Alberto Pilotto, Antonio Greco et al. · 2016 · Expert Opinion on Pharmacotherapy
  76. Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer’s Disease and Other Tauopathies
    Umesh K. Jinwal, Anastasia Groshev, Juan Zhang, Aditya Grover, Vijaykumar B. Sutariya · 2013 · Current Drug Delivery
  77. Methylene blue treatment in experimental ischemic stroke: A mini-review
    Jiang Zhao, TimothyQ Duong · 2016 · Brain Circulation
  78. Altered Proteostasis in Neurodegenerative Tauopathies
    Katerina Papanikolopoulou, Efthimios M. C. Skoulakis · 2020 · Advances in experimental medicine and biology
  79. An evaluation of hydromethylthionine as a treatment option for Alzheimer’s disease
    Nader Hashweh, Zachary Bartochowski, Rita Khoury, George Thomas Grossberg · 2020 · Expert Opinion on Pharmacotherapy
  80. Inhibitors of heat shock protein 70 (Hsp70) with enhanced metabolic stability reduce tau levels
    Hao Shao, Xiaokai Li, Shigenari Hayashi, Jeanette L. Bertron, Daniel M. C. Schwarz, Benjamin C. Tang, Jason E. Gestwicki · 2021 · Bioorganic & Medicinal Chemistry Letters
  81. Tauopathies: Mechanisms and Therapeutic Strategies
    Chen‐Chen Tan, Xiao-Yan Zhang, Lan Tan, Jin‐Tai Yu · 2017 · Journal of Alzheimer s Disease
  82. Equilibrium Study, Modeling and Optimization of Model Drug Adsorption Process by Sunflower Seed Shells
    Bahdja Hayoun, Mustapha Bourouina, Marta M. Pazos, M.Á. Sanromán, Saliha Bourouina Bacha · 2020 · Applied Sciences
  83. The next step of neurogenesis in the context of Alzheimer’s disease
    Hamid Reza Moradi, Vahid Hajali, Zabihollah Khaksar, Farzaneh Vafaee, Fatemeh Forouzanfar, Sajad Sahab Negah · 2021 · Molecular Biology Reports
  84. Assessing the degradation of tau in primary neurons: The role of autophagy
    Changyi Ji, Maoping Tang, Gail V.W. Johnson · 2017 · Methods in cell biology
  85. Should drug discovery scientists still embrace the amyloid hypothesis for Alzheimer’s disease or should they be looking elsewhere?
    Bruno Pietro Imbimbo, Stefania Ippati, Mark Watling · 2020 · Expert Opinion on Drug Discovery
  86. Exposure to Manganese Induces Autophagy–Lysosomal Pathway Dysfunction-Mediated Tauopathy by Activating the cGAS–STING Pathway in the Brain
    Xin Zhang, Jingjing Liu, Shiyin Zhong, Zhimin Zhang, Qiongli Zhou, Jirui Yang, Xuhong Chang, Hui Wang · 2024 · Environment & Health
  87. Alzheimer’s disease: an axonal injury disease?
    Dan Liang, Zhaohui Zhang · 2023 · Frontiers in Aging Neuroscience
  88. Molecular Basis of Neuronal Autophagy in Ageing: Insights from Caenorhabditis elegans
    Georgios Konstantinidis, Nektarios Tavernarakis · 2021 · Cells
  89. Methylene Blue Blocks and Reverses the Inhibitory Effect of Tau on PMCA Function
    Berrocal, Maria, Caballero-Bermejo, Montaña, Gutierrez-Merino, Carlos, Mata, Ana M. · 2019 · International Journal of Molecular Sciences
  90. Membrane estrogen receptor ERα activation improves tau clearance via autophagy induction in a tauopathy cell model
    Angélica Jardim Costa, Rafaela Brito Oliveira, Patrícia Wachilewski, Michelle Sayuri Nishino, Taysa Bervian Bassani, Roberta Sessa Stilhano, Janete Maria Cerutti, Bruno Heidi Nakano Nozima, Catarina Segreti Porto, Gustavo J.S. Pereira et al. · 2022 · Brain Research
  91. Methylene blue treatment delays progression of perfusion–diffusion mismatch to infarct in permanent ischemic stroke
    Pavel Rodriguez, Jiang Zhao, Shi‐Liang Huang, Qiang Shen, Timothy Q. Duong · 2014 · Brain Research
  92. Heat shock proteins regulates Tau protein aggregation in Alzheimer’s disease
    Subashchandrabose Chinnathambi · 2024 · Advances in protein chemistry and structural biology
  93. Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies
    Ya-Qing Li, M. Tan, Jin-Tai Yu, L. Tan · 2015 · Molecular Neurobiology
  94. Modulation of autophagy as a therapeutic target for Alzheimer’s disease
    John Steele, Emily Y. Fan, Yildiz Kelahmetaglu, Yuan Tian, Victor Bustos · 2013 · Postdoc Journal
  95. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies
    Stefano Gazzina, Marta Antonia Manes, Alessandro Padovani, Barbara Borroni · 2017 · European Journal of Pharmacology
  96. Cannabidiol-Induced Autophagy Ameliorates Tau Protein Clearance
    Talita Aparecida de Moraes Vrechi, Gabriel Cicolin Guarache, Rafaela Brito Oliveira, Érika da Cruz Guedes, Adolfo Garcia Erustes, Anderson H.F.F. Leão, Vanessa Costhek Abílio, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa et al. · 2025 · Neurotoxicity Research
  97. Inhibitory Effects of Macelignan on Tau Phosphorylation and Aβ Aggregation in the Cell Model of Alzheimer's Disease
    Liang Gu, Nan Cai, Meiting Li, Decheng Bi, Lijun Yao, Weishan Fang, Yan Ling Wu, Zhangli Hu, Qiong Liu, Zhijian Lin et al. · 2022 · Frontiers in Nutrition
  98. Methotrimeprazine is a neuroprotective antiviral in JEV infection via adaptive ER stress and autophagy
    Surendra Kumar Prajapat, Laxmi Mishra, Sakshi Khera, Shadrack D Owusu, Kriti Ahuja, Puja Sharma, Eira Choudhary, Simran Chhabra, Niraj Kumar, Rajan Singh et al. · 2024 · EMBO Molecular Medicine
  99. Emerging amyloid and tau targeting treatments for Alzheimer’s disease
    Ayesha Khan, Anne Corbett, Clive G. Ballard · 2017 · Expert Review of Neurotherapeutics
  100. Activation of Nrf2 by methylene blue is associated with the neuroprotection against MPP+ induced toxicity via ameliorating oxidative stress and mitochondrial dysfunction
    Sunil Bhurtel, Eugene Bok, Nikita Katila, Jaekwang Kim, Dong‐Young Choi · 2021 · Biochemical Pharmacology